- Home
- ESPR vs EPSM Comparison
ESPR vs EPSM Comparison
Compare ESPR & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- EPSM
- Stock Information
- Founded
- ESPR 2008
- EPSM 2010
- Country
- ESPR United States
- EPSM China
- Employees
- ESPR N/A
- EPSM N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- EPSM
- Sector
- ESPR Health Care
- EPSM
- Exchange
- ESPR Nasdaq
- EPSM Nasdaq
- Market Cap
- ESPR 208.1M
- EPSM 185.6M
- IPO Year
- ESPR 2013
- EPSM 2025
- Fundamental
- Price
- ESPR $0.85
- EPSM $15.77
- Analyst Decision
- ESPR Buy
- EPSM
- Analyst Count
- ESPR 7
- EPSM 0
- Target Price
- ESPR $5.93
- EPSM N/A
- AVG Volume (30 Days)
- ESPR 6.2M
- EPSM 517.6K
- Earning Date
- ESPR 05-06-2025
- EPSM 01-01-0001
- Dividend Yield
- ESPR N/A
- EPSM N/A
- EPS Growth
- ESPR N/A
- EPSM N/A
- EPS
- ESPR N/A
- EPSM 0.02
- Revenue
- ESPR $259,574,000.00
- EPSM $12,518,070.00
- Revenue This Year
- ESPR $4.07
- EPSM N/A
- Revenue Next Year
- ESPR N/A
- EPSM N/A
- P/E Ratio
- ESPR N/A
- EPSM $771.01
- Revenue Growth
- ESPR 12.99
- EPSM N/A
- 52 Week Low
- ESPR $0.69
- EPSM $4.23
- 52 Week High
- ESPR $3.94
- EPSM $17.63
- Technical
- Relative Strength Index (RSI)
- ESPR 44.65
- EPSM N/A
- Support Level
- ESPR $0.79
- EPSM N/A
- Resistance Level
- ESPR $0.88
- EPSM N/A
- Average True Range (ATR)
- ESPR 0.07
- EPSM 0.00
- MACD
- ESPR 0.02
- EPSM 0.00
- Stochastic Oscillator
- ESPR 69.48
- EPSM 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.